Abivax says no stabilization trades executed, stabilization period ends

Abivax SA Sponsored ADR
MNSN HOLDINGS INC

Abivax SA Sponsored ADR

ABVX

0.00

MNSN HOLDINGS INC

MNSH

0.00
  • Abivax closed its stabilization period with no stabilization transactions, per the stabilizing agent Leerink Partners.
  • Update followed full exercise of the underwriters’ overallotment option for 960,000 additional ADS, lifting the deal to 7,360,000 ADS.
  • Gross proceeds rose to USD 920 million; estimated net proceeds to USD 874.1 million.
  • Settlement for the additional ADS expected alongside the offering close on July 6, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief via EQS News (Ref. ID: fr_reg_2358406_fr) on July 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.